ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.
ETFOptimize | HOME
Close Window
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AI-Powered Skin Diagnostics Available Through PatientNow and Skintelligent Partnership

By: PRLog

DENVER - May 31, 2024 - PRLog -- Skintelligent and PatientNow are excited to announce their strategic partnership aimed at transforming the landscape of the aesthetic industry. By combining Skintelligent's cutting-edge AI skin imaging technology with PatientNow's comprehensive suite of practice management solutions, aesthetic practices can now elevate patient acquisition, treatment acceptance, retention, and more to unprecedented levels.

The collaboration between Skintelligent and PatientNow marks a significant milestone in the medical aesthetics industry, offering practitioners powerful innovation  to enhance patient care, streamline operations, and boost revenue. Patients can utilize Skintelligent's skin imaging tool, which uses artificial intelligence, through the PatientNow platform. Combined with PatientNow's lead acquisition forms and communication automation, this enables practitioners to provide personalized treatment recommendations tailored to each patient's unique needs.

Eleanor Jones, CEO of Skintelligent, expressed her enthusiasm about the partnership, stating, "We are thrilled to join forces with PatientNow to revolutionize the way aesthetic practices engage with patients. By leveraging our AI skin imaging technology with PatientNow's practice management solutions, we are making it that much easier for practitioners to deliver personalized care that drives growth and enhances patient loyalty."

Bethany Little, CEO of PatientNow, echoed Jones's sentiments, emphasizing the transformative impact of the partnership. "As the aesthetics industry becomes more competitive, practices need to stand out to attract new clients.  Skintelligent's AI-powered skin diagnostics coupled with PatientNow's marketing automation engine will convert clients like no other technology offering in the marketplace," said Little.

Together, Skintelligent and PatientNow are set to advance the field of aesthetics, equipping practitioners with state-of-the-art tools to enhance patient acquisition, practice efficiency, and revenue growth.

To learn more about how medical spas, dermatology, plastic surgery, and other aesthetic practices can leverage these tools, register for the upcoming webinar on Tuesday, June 4, 2024 here.

About Skintelligent: Skintelligent develops Digital Skin Advisors to drive growth and patient experience for medical spas and dermatology practices. Leveraging AI skin imaging and personalized treatment recommendations, Skintelligent's software enhances marketing funnels and fosters patient loyalty. Clinically validated, Skintelligent's AI technology represents a cutting-edge solution for aesthetic practices seeking to elevate patient care and practice management.

About PatientNow: PatientNow is a leading provider of practice management solutions for the medical aesthetics industry. Empowering practices with innovative solutions, PatientNow's comprehensive platform optimizes patient care, practice management, and business growth. With a commitment to innovation, integration, and strategic partnerships, PatientNow is dedicated to revolutionizing the aesthetic practice management landscape.

Contact
PatientNow
***@patientnow.com
Photos: (Click photo to enlarge)

PatientNow + Skintelligent Webinar: Leveraging AI in Your Practice


Source: PatientNow

Read Full Story - AI-Powered Skin Diagnostics Available Through PatientNow and Skintelligent Partnership | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 
IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.